Reference:WMA Declaration of Helsinki 2024 34

Document information
Reference	WMA Declaration of Helsinki 2024
Validity area	WMA
Scope(s)	G
Document name	Declaration of Helsinki
Version / Revision	2024
Status	Current
Document type	International guideline
Language(s)	EN
Description	Declaration of Helsinki Medical Research Involving Human Participants The Declaration of Helsinki (DoH) is the World Medical Association’s (WMA) best-known policy statement. The first version was adopted in 1964 and has been amended seven times since, most recently at the General Assembly in October 2024. The current (2024) version is the only official one; all previous versions* have been replaced and should not be used or cited except for historical purposes. The WMA would like to thank all those who submitted comments and suggestions for the most recent revision of the DoH.
Official source	Official link
Restricted access	No
Submitted by	Florian Adragna
Contributors

Reference Details
Scope	G
Document part	34
Language	EN
Original entry by	Florian Adragna
Contributors
Tags (EN)
Tags (original language)
Tags (FR)
Comment	Post-trial provisions: arrangements to be made in advance

Content

Post-Trial Provisions 34. In advance of a clinical trial, post-trial provisions must be arranged by sponsors and researchers to be provided by themselves, healthcare systems, or governments for all participants who still need an intervention identified as beneficial and reasonably safe in the trial. Exceptions to this requirement must be approved by a research ethics committee. Specific information about post-trial provisions must be disclosed to participants as part of informed consent.